KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) FCF Margin (2016 - 2025)

Biogen has reported FCF Margin over the past 17 years, most recently at 20.53% for Q4 2025.

  • Quarterly results put FCF Margin at 20.53% for Q4 2025, down 886.0% from a year ago — trailing twelve months through Dec 2025 was 20.73% (down 739.0% YoY), and the annual figure for FY2025 was 20.73%, down 739.0%.
  • FCF Margin for Q4 2025 was 20.53% at Biogen, down from 48.38% in the prior quarter.
  • Over the last five years, FCF Margin for BIIB hit a ceiling of 48.38% in Q3 2025 and a floor of 10.28% in Q4 2022.
  • Median FCF Margin over the past 5 years was 23.07% (2022), compared with a mean of 20.7%.
  • Biggest five-year swings in FCF Margin: skyrocketed 4466bps in 2021 and later crashed -3905bps in 2022.
  • Biogen's FCF Margin stood at 28.78% in 2021, then crashed by -136bps to 10.28% in 2022, then surged by 79bps to 2.21% in 2023, then skyrocketed by 1431bps to 29.4% in 2024, then plummeted by -30bps to 20.53% in 2025.
  • The last three reported values for FCF Margin were 20.53% (Q4 2025), 48.38% (Q3 2025), and 5.08% (Q2 2025) per Business Quant data.